Trial Profile
Phase 2 Clinical Study of Bepotastine Besilate Nasal Spray for the Treatment of Symptoms Associated with Seasonal Allergic Rhinitis.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Oct 2020
Price :
$35
*
At a glance
- Drugs Bepotastine (Primary)
- Indications Seasonal allergic rhinitis
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- Sponsors Bausch & Lomb
- 01 May 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 28 Apr 2011 Positive topline results reported in an ISTA Pharmaceuticals media release.
- 15 Dec 2010 New trial record